Physician

Anupam Basuray, M.D.

According to 2025 Medicare claims, Anupam Basuray, M.D. (NPI: 1659536894) practices advanced heart failure and transplant cardiology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is OHIOHEALTH CORPORATION (NPI: 1578545273; TIN: 311351965) and primary practice location at 43214-3908.

Basuray's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 262 traditional Medicare patients, billed 620 HCPCS/CPT codes, and received $50,393 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 3,191 prescription claims across 458 beneficiaries totaling $3,693,824 in drug costs, led by Vyndamax (Tafamidis). 2021 DME data shows 12 claims. Open Payments data shows 18 records totaling $276,047. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $19,959 to $3,693,824. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	203	778	$40,136
2016	192	822	$44,834
2017	240	827	$44,595
2018	263	723	$42,951
2019	280	694	$45,964
2020	310	690	$47,180
2021	314	561	$44,061
2022	252	489	$38,803
2023	277	529	$47,036
2024	262	620	$50,393

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	111	734	$19,959
2016	119	1,166	$46,685
2017	163	1,423	$75,460
2018	201	1,623	$126,704
2019	222	1,794	$594,970
2020	252	2,088	$1,040,074
2021	283	1,963	$1,031,963
2022	313	1,980	$1,243,221
2023	407	2,648	$1,734,732
2024	458	3,191	$3,693,824

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	11	$19,644
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	115	$5,946
2021	N/R	12	$384
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	33	33	$130
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	50	68	$108
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	51	106	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	112	126	$72
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	70	80	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	80	2,580	$1,986,745
Vyndaqel	Tafamidis Meglumine	34	1,020	$744,220
Entresto	Sacubitril/Valsartan	307	14,777	$320,021
Farxiga	Dapagliflozin Propanediol	187	9,735	$173,050
Jardiance	Empagliflozin	109	6,504	$126,228

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$508	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	8	$275,539	Medtronic, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anupam Basuray, M.D.?

Tedicare shows public-source Medicare data for Anupam Basuray, M.D. (NPI 1659536894), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anupam Basuray, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anupam Basuray, M.D.?

Anupam Basuray, M.D. is linked to OHIOHEALTH CORPORATION (billing NPI 1578545273) in the available physician profile data.

Does Anupam Basuray, M.D. have Open Payments data?

Anupam Basuray, M.D. has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.